renin-angiotensin system antagonists, glomerular filtration rate and blood pressure
Clicks: 270
ID: 191692
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
270 views
43 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #15 of 39 articles by views in oncology letters
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The article deals with the mModern data on the influence of renin-angiotensin system blockers on the glomerular filtration rate, the level of arterial pressure and the outcome of chronic kidney disease. The strategy of rennin-angiotensine blockade is offered to be changed depending on the criteria values of glomerular filtration rate: a combination of inhibitors of angiotensin-converting enzyme + angiotensin receptors blockers, monotherapy and drug withdrawal in glomerular filtration rate under 15–30 ml/min/m2. The formula BRIMONEL for treatment of chronic kidney disease is given.
| Reference Key |
ivanov2018pokirenin-angiotensin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;D.D. Ivanov |
| Journal | oncology letters |
| Year | 2018 |
| DOI |
10.22141/2307-1257.7.1.2018.122214
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.